美股市場個股詳情

HALO 奧洛茲美醫療

添加自選

38.570
+0.110+0.29%

收盤價 04/26 16:00 (美東)

37.130
-1.440-3.73%

盤後 19:49 (美東)

49.00億總市值18.37市盈率TTM

奧洛茲美醫療股票討論區

登錄發表評論

Moomoo AI

02/19 19:59

EPS growth outshines yearly share price gain, hinting at cautious market sentiment. Despite recent sell-off, long-term investors see 16% annual return over five years, suggesting sell-off may be an opportunity for those seeking long-term growth.

Halozyme Therapeutics' (NASDAQ:HALO) Investors Will Be Pleased With Their Impressive 107% Return Over the Last Five Years

Moomoo AI

2023/12/25 19:09

The insider stock selling at Halozyme Therapeutics could raise concerns among shareholders. However, the fact that insiders maintain a considerable amount of shares might suggest some level of alignment between management and smaller shareholders.

Halozyme Therapeutics Insiders Sell US$1.8m Of Stock, Possibly Signalling Caution

Moomoo AI

2023/11/28 18:48

Confidence in Halozyme Therapeutics is suggested due to solid EPS growth and significant insider investment aligning with shareholders' interests.

Should You Be Adding Halozyme Therapeutics (NASDAQ:HALO) To Your Watchlist Today?

逍遥投资派

2023/01/15 23:33

$奧洛茲美醫療(HALO.US)$營收2018年大跌一半至1.5億，之後三年快速增長到4.4億，營業利潤則是在2020年扭虧達到1.4億，2021年達到2.8億，淨利潤2020年達到1.3億，2021年達到4億。
2022前三季度營收增長40%達到4.8億，但由於費用的大幅增長，營業利潤反而下滑12%，淨利潤下滑57%到1.44億。
目前市盈率18.4，市盈率TTM已經達到了34，看起來全年結果也不會太好，目前沒有吸引力。

已翻譯

暫無評論

分析

分析師評級

暫無數據

目標價預測

暫無數據

熱議

美股

綜合熱度